Ionis Pharmaceuticals Q2 Adjusted Operating Expenses USD 325 Million
IONS•Q2 financial results
Jul 29 (Reuters) - Ionis Pharmaceuticals Q2 net income USD 115 million.
- Q2 operating expenses USD 370 million
- Q2 adjusted operating income USD -57 million vs. IBES estimate USD -178.4 million
- Q2 operating income USD -102 million
Related News
Lighthouse Canton says memory-chip selloff diverges from earnings, flags opportunity to sell elevated volatility
SOXX•
Uber Eats partners with Busch's Fresh Food Market, Hays, Lowe's Market, Piggly Wiggly for US grocery delivery expansion
UBER•
